FINNENCE ▪ THE WIRE FILE
THE WIRE · № 67710
Company■ Unclear/unknown
New Phase 3 trial: Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury — Pharmazz, Inc.
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-06 12:00 UTC
LAST UPDATE2026-10-06 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A new TBI trial targets an unmet need, but not-yet-recruiting status means no near-term readout.
Early-stage TBI trial has no near-term catalyst
CATALYST TO WATCH
Trial enrollment and interim data
MAIN RISK
Trial may fail or be delayed
FULL DISPATCH
Sponsor: Pharmazz, Inc.; Status: Not Yet Recruiting; Conditions: Traumatic Brain Injury; Interventions: Placebo, Sovateltide; Enrollment: 214 (estimated); First posted: 2026-10-06; NCT: NCT07861126
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery — Vascular Therapies, Inc.2026-10-06 12:00 UTC
Phase 3 results posted: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery — Vascular Therapies, Inc.2026-10-06 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Janssen Research & Development, LLC2026-10-06 12:00 UTC
Phase 3 results posted: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Janssen Research & Development, LLC2026-10-06 12:00 UTC
→CORRELATIONshares Healthcare
Biobeat Brings Leading Hypertension Voices to AHA Hypertension Scientific Sessions as Conversation Shifts to Cuffless 24-Hour Ambulatory Blood Pressure Monitoring2026-10-06 17:24 UTC
Biobeat Brings Leading Hypertension Voices to AHA Hypertension Scientific Sessions as Conversation Shifts to Cuffless 24-Hour Ambulatory Blood Pressure Monitoring2026-10-06 17:24 UTC
→CORRELATIONshares Healthcare
InventHelp Inventor Develops HS Pain Relief Patch (MBQ-984)2026-10-06 17:30 UTC
InventHelp Inventor Develops HS Pain Relief Patch (MBQ-984)2026-10-06 17:30 UTC
→CORRELATIONshares Healthcare
HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life2026-10-06 17:36 UTC
HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life2026-10-06 17:36 UTC
→CORRELATIONshares Healthcare
icotec Receives CMS approval for New Technology Add-On Payment for its CMORE® CT System2026-10-06 18:01 UTC
icotec Receives CMS approval for New Technology Add-On Payment for its CMORE® CT System2026-10-06 18:01 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.